Mukka Proteins Ltd

Mukka Proteins Ltd

$MUKKAAnimal FeedNSEBSE

Mukka Proteins Ltd (MUKKA) last traded at ₹25.9, a market capitalisation of ₹778 crore, on a P/E of 11.3. Over the past 52 weeks the stock has ranged between ₹18.3 and ₹31.2. Mukka Proteins Ltd last reported results for the quarter ended Jun 2026, with sales of ₹490 crore and net profit of ₹19 crore. Mukka Proteins Ltd’s annual general meeting is scheduled for 10 Sept 2026. Figures are as of 25 Aug 2026 and are not real time.

Mukka Proteins Ltd share price and key metrics

Current price
₹25.9
Market cap
₹778 cr
Stock P/E
11.3
Book value
₹16.6
ROE
11.1%
ROCE
11.6%
Dividend yield
0.00%
52w high / low
31.2/18.3

Metrics as of 25 Aug 2026. Not real time.

Mukka Proteins Ltd quarterly results

In the quarter ended Jun 2026, sales were ₹490 cr, up 186.5% from ₹171 cr a year earlier. Net profit was ₹19 cr, up 850.0% year on year.

Mukka Proteins Ltd consolidated quarterly results, figures in ₹ crore
₹ croreSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales149303382171245654381490
Expenses140262352157224608347443
Operating profit1041291420453447
OPM %6%14%8%8%8%7%9%10%
Other income464368152
Interest911101113151516
Depreciation44334455
Profit before tax1332029352927
Tax %-40%19%30%33%26%21%26%32%
Net profit1271427272119
EPS (₹)0.070.880.450.050.200.790.690.63

Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.

Mukka Proteins Ltd annual results

Mukka Proteins Ltd annual profit and loss, figures in ₹ crore
₹ croreMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales6047701,1771,3801,0061,4491,768
Operating profit22488610595115147
OPM %3.6%6%7%8%9%8%8%
Net profit11264874485774
EPS (₹)1.102.002.341.551.742.31

TTM is the trailing twelve months to the most recent quarter.

Mukka Proteins Ltd growth and returns

Compounded Sales Growth
10 Years
%
5 Years
19%
3 Years
7%
TTM
76%
Compounded Profit Growth
10 Years
%
5 Years
53%
3 Years
6%
TTM
59%
Stock Price CAGR
10 Years
%
5 Years
%
3 Years
%
1 Year
-4%
Return on Equity
10 Years
%
5 Years
17%
3 Years
14%
Last Year
11%

Mukka Proteins Ltd shareholding pattern

Promoters held 73.33% at Jun 2026, broadly unchanged since Jun 2025. FIIs 1.73% and DIIs 0.00%.

Mukka Proteins Ltd shareholding pattern by quarter, in percent
% heldSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters73.33%73.33%73.33%73.33%73.33%73.33%73.33%73.33%
FIIs2.81%2.63%2.63%2.08%1.70%1.70%1.70%1.73%
DIIs2.00%1.98%1.98%1.87%1.66%0.17%0.00%0.00%
Public21.84%22.06%22.05%22.71%23.31%24.80%24.97%24.93%
No. of shareholders1,44,5491,46,0621,47,3081,45,3431,41,6491,37,9201,32,0981,27,922

As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.

When is Mukka Proteins Ltd’s AGM?

Mukka Proteins Ltd’s annual general meeting is scheduled for 10 Sept 2026.

  • AGM16th Annual General Meeting

See the full results calendar for every Indian company reporting in the next 30 days.

Mukka Proteins Ltd corporate filings

  • Clarification w.r.t. intimations dated 12th August 2026 regarding investment in Swaccha Eco Solutions Private Limited.Company Updatelow impact
    Filing PDF

    Cruxal's analysis: Mukka Proteins has issued a clarification regarding its previous intimation dated 12th…

    Read the full analysis
  • Intimation regarding Newspaper publication of Notice of 16th Annual General Meeting.Company Updatelow impact
    Filing PDF

    Cruxal's analysis: Mukka Proteins Ltd has issued a formal intimation regarding the publication of the notice…

    Read the full analysis
  • Intimation of dispatch of letter to shareholders whose e-mail addresses are not registered with the Company/Depositories.Company Updatelow impact
    Filing PDF

    Cruxal's analysis: Mukka Proteins Ltd has announced the dispatch of physical letters to shareholders who…

    Read the full analysis
  • Annual Report for the Financial Year 2025-26Otherslow impact
    Filing PDF

    Cruxal's analysis: Mukka Proteins Ltd has filed its Annual Report for the financial year 2025-26, dated…

    Read the full analysis
  • Notice of 16th Annual General Meeting to be held on Thursday, 10th September 2026.AGM/EGMhigh impact
    Filing PDF

    Cruxal's analysis: Mukka Proteins Limited has scheduled its 16th Annual General Meeting for September 10…

    Read the full analysis
  • Newspaper publication of intimation of 16th Annual General Meeting.Company Updatelow impact
    Filing PDF

    Cruxal's analysis: Mukka Proteins Ltd has published the mandatory newspaper intimation regarding its 16th…

    Read the full analysis
  • Intimation regarding 16th AGM to be held on Thursday, 10th September 2026.Company Updatelow impact
    Filing PDF

    Cruxal's analysis: Mukka Proteins Limited has formally intimated the stock exchanges regarding the…

    Read the full analysis
  • Intimation regarding newspaper publication of Q1 FY 27 Financials Results.Company Updatelow impact
    Filing PDF

    Cruxal's analysis: Mukka Proteins Limited has released its unaudited standalone and consolidated financial…

    Read the full analysis
  • Intimation on Investor Presentation - Q1 FY 27Company Updatehigh impact
    Filing PDF

    Cruxal's analysis: Mukka Proteins Limited released its Q1 FY27 investor presentation, reporting revenue from…

    Read the full analysis
  • Intimation on Press Release.Company Updatelow impact
    Filing PDF

    Cruxal's analysis: Mukka Proteins Ltd has submitted a formal intimation regarding a press release under…

    Read the full analysis
  • Intimation regarding acquisition of Swachha Eco Solutions Private Limited.Company Updatemedium impact
    Filing PDF

    Cruxal's analysis: Mukka Proteins Limited has announced a strategic investment of INR 64.93 lakh to acquire…

    Read the full analysis
  • Intimation regarding withdrawal of NCD issuance.Company Updatelow impact
    Filing PDF

    Cruxal's analysis: Mukka Proteins Limited has formally rescinded its earlier board approval from 15th May…

    Read the full analysis
  • Intimation of Re-appointment of Directors.Company Updatelow impact
    Filing PDF

    Cruxal's analysis: Mukka Proteins Limited has announced the re-appointment of its Managing Director, Chief…

    Read the full analysis
  • Outcome of the Board Meeting held on 12th August 2026Board Meetinghigh impact
    Filing PDF

    Cruxal's analysis: Mukka Proteins Limited reported robust consolidated financial results for the quarter…

    Read the full analysis
  • Intimation of Postal Ballot Minutes.AGM/EGMhigh impact
    Filing PDF

    Cruxal's analysis: Mukka Proteins Limited has received shareholder approval via postal ballot to issue up to…

    Read the full analysis
  • Mukka Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve unaudited financial results ....Board Meetinglow impact
    Filing PDF

    Cruxal's analysis: Mukka Proteins Limited has formally intimated the stock exchanges regarding a Board of…

    Read the full analysis
  • Intimation of receipt of final order from CESTAT, Bangalore.Company Updatehigh impact
    Filing PDF

    Cruxal's analysis: Mukka Proteins Limited has received a favorable ruling from the CESTAT, Bangalore, which…

    Read the full analysis

This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.

Track Mukka Proteins Ltd

Cruxal reads every Mukka Proteins Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.

Cruxal publishes market data and coverage for information only. Nothing here is investment advice.